Inhalable IgG Synthesis For Influenza Immunoprophylaxis

Award Information
Agency:
Department of Health and Human Services
Branch
n/a
Amount:
$99,600.00
Award Year:
2004
Program:
SBIR
Phase:
Phase I
Contract:
1R43AI053906-01A1
Agency Tracking Number:
AI053906
Solicitation Year:
2004
Solicitation Topic Code:
n/a
Solicitation Number:
PHS2004-2
Small Business Information
AKTIV-DRY, LLC
AKTIV-DRY, LLC, 6060 SPINE RD, BOULDER, CO, 80302
Hubzone Owned:
N
Socially and Economically Disadvantaged:
N
Woman Owned:
N
Duns:
n/a
Principal Investigator:
STEPHEN Cape
(303) 499-1188
CAPE@CIRES.COLORADO.EDU
Business Contact:
(303) 697-6143
Research Institution:
n/a
Abstract
DESCRIPTION (provided by applicant): This Phase I SBIR proposal is the first step in the development of inhalable IgG microparticles for immunoprophylaxis against Influenza A, a category C Priority Pathogen. In Phase I, Aktiv-Dry will simultaneously s

* information listed above is at the time of submission.

Agency Micro-sites

US Flag An Official Website of the United States Government